Avanir Targets Watson In Suit Over Nuedexta Patents
Avanir Pharmaceuticals Inc. sued drugmaker Watson Pharmaceuticals Inc. in Delaware on Friday in an effort to block plans to market a generic version of so-called involuntary emotion drug Nuedexta, the latest...To view the full article, register now.
Already a subscriber? Click here to view full article